Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation

Abstract

Recently, the orphan receptor G protein-coupled receptor 55 (GPR55) has been proposed as a potential cannabinoid receptor, although controversy remains on its physiological roles. Current evidence suggests a role for GPR55 as a receptor for the lysophospholipid lysophosphatidylinositol (LPI). In this study, we show that GPR55 is expressed in several prostate and ovarian cancer cell lines, both at the mRNA and at the protein level, and that it has a critical role in regulating proliferation and anchorage-independent growth. We further show that GPR55 mediates the effects of LPI in prostate and ovarian cancer cells. Indeed we demonstrate that LPI is able to induce calcium mobilization and activation of Akt and extracellular signal-regulated kinase (ERK)1/2 in these cells and that both pharmacological blockade of GPR55 and its downregulation using specific small interfering RNA strongly inhibits these processes. We further identify an autocrine loop by which LPI is synthesized by cytosolic phospholipase A2, pumped out of the cell by the ATP-binding cassette transporter ABCC1/MRP1, and is then able to initialize cascades downstream of GPR55. All together, these data demonstrate a role of LPI and its receptor GPR55 in cancer cells in activating an autocrine loop that regulates cell proliferation. These findings may have important implications for LPI as a novel cancer biomarker and for its receptor GPR55 as a potential therapeutic target.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

References

  • Davies MA, Koul D, Dhesi H, Berman R, McDonnell TJ, McConkey D et al. (1999). Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN. Cancer Res 59: 2551–2556.

    CAS  PubMed  Google Scholar 

  • Falasca M, Corda D . (1994). Elevated levels and mitogenic activity of lysophosphatidylinositol in k-ras-transformed epithelial cells. Eur J Biochem 221: 383–389.

    Article  CAS  PubMed  Google Scholar 

  • Falasca M, Iurisci C, Carvelli A, Sacchetti A, Corda D . (1998). Release of the mitogen lysophosphatidylinositol from H-Ras-transformed fibroblasts; a possible mechanism of autocrine control of cell proliferation. Oncogene 16: 2357–2365.

    Article  CAS  PubMed  Google Scholar 

  • Falasca M, Silletta MG, Carvelli A, Di Francesco AL, Fusco A, Ramakrishna V et al. (1995). Signalling pathways involved in the mitogenic action of lysophosphatidylinositol. Oncogene 10: 2113–2124.

    CAS  PubMed  Google Scholar 

  • Ford LA, Roelofs AJ, Anavi-Goffer S, Mowat L, Simpson DG, Irving AJ et al. (2010). A role for L-alpha-lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells. Br J Pharmacol 160: 762–771.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Henstridge CM, Balenga NA, Ford LA, Ross RA, Waldhoer M, Irving AJ . (2009). The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation. FASEB J 23: 183–193.

    Article  CAS  PubMed  Google Scholar 

  • Hoffmann U, Kroemer HK . (2004). The ABC transporters MDR1 and MRP2: multiple functions in disposition of xenobiotics and drug resistance. Drug Metab Rev 36: 669–701.

    Article  CAS  PubMed  Google Scholar 

  • Kapur A, Zhao P, Sharir H, Bai Y, Caron MG, Barak LS et al. (2009). Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands. J Biol Chem 284: 29817–29827.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kreitzer FR, Stella N . (2009). The therapeutic potential of novel cannabinoid receptors. Pharmacol Ther 122: 83–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lauckner JE, Jensen JB, Chen HY, Lu HC, Hille B, Mackie K . (2008). GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. Proc Natl Acad Sci USA 105: 2699–2704.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mitra P, Oskeritzian CA, Payne SG, Beaven MA, Milstien S, Spiegel S . (2006). Role of ABCC1 in export of sphingosine-1-phosphate from mast cells. Proc Natl Acad Sci USA 103: 16394–16399.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Monet M, Gkika D, Lehen′kyi V, Pourtier A, Vanden Abeele F, Bidaux G et al. (2009). Lysophospholipids stimulate prostate cancer cell migration via TRPV2 channel activation. Biochim Biophys Acta 1793: 528–539.

    Article  CAS  PubMed  Google Scholar 

  • Nevalainen T, Irving AJ . (2010). GPR55, a lysophosphatidylinositol receptor with cannabinoid sensitivity? Curr Top Med Chem 10: 799–813.

    Article  CAS  PubMed  Google Scholar 

  • Oka S, Kimura S, Toshida T, Ota R, Yamashita A, Sugiura T . (2010). Lysophosphatidylinositol induces rapid phosphorylation of p38 mitogen-activated protein kinase and activating transcription factor 2 in HEK293 cells expressing GPR55 and IM-9 lymphoblastoid cells. J Biochem 147: 671–678.

    Article  CAS  PubMed  Google Scholar 

  • Oka S, Nakajima K, Yamashita A, Kishimoto S, Sugiura T . (2007). Identification of GPR55 as a lysophosphatidylinositol receptor. Biochem Biophys Res Commun 362: 928–934.

    Article  CAS  PubMed  Google Scholar 

  • Patel MI, Singh J, Niknami M, Kurek C, Yao M, Lu S et al. (2008). Cytosolic phospholipase A2-alpha: a potential therapeutic target for prostate cancer. Clin Cancer Res 14: 8070–8079.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pettus BJ, Bielawska A, Subramanian P, Wijesinghe DS, Maceyka M, Leslie CC et al. (2004). Ceramide 1-phosphate is a direct activator of cytosolic phospholipase A2. J Biol Chem 279: 11320–11326.

    Article  CAS  PubMed  Google Scholar 

  • Ross RA . (2009). The enigmatic pharmacology of GPR55. Trends Pharmacol Sci 30: 156–163.

    Article  CAS  PubMed  Google Scholar 

  • Ryberg E, Larsson N, Sjögren S, Hjorth S, Hermansson NO, Leonova J et al. (2007). The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol 152: 1092–1101.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sawzdargo M, Nguyen T, Lee DK, Lynch KR, Cheng R, Heng HH et al. (1999). Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain. Brain Res Mol Brain Res 64: 193–198.

    Article  CAS  PubMed  Google Scholar 

  • Sharir H, Abood ME . (2010). Pharmacological characterization of GPR55, a putative cannabinoid receptor. Pharmacol Ther 126: 301–313.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Soga T, Ohishi T, Matsui T, Saito T, Matsumoto M, Takasaki J et al. (2005). Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor. Biochem Biophys Res Commun 326: 744–751.

    Article  CAS  PubMed  Google Scholar 

  • Staton PC, Hatcher JP, Walker DJ, Morrison AD, Shapland EM, Hughes JP et al. (2008). The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain. Pain 139: 225–236.

    Article  CAS  PubMed  Google Scholar 

  • Sullivan GF, Amenta PS, Villanueva JD, Alvarez CJ, Yang JM, Hait WN . (1998). The expression of drug resistance gene products during the progression of human prostate cancer. Clin Cancer Res 4: 1393–1403.

    CAS  PubMed  Google Scholar 

  • Sullivan GF, Yang JM, Vassil A, Yang J, Bash-Babula J, Hait WN . (2000). Regulation of expression of the multidrug resistance protein MRP1 by p53 in human prostate cancer cells. J Clin Invest 105: 1261–1267.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sutphen R, Xu Y, Wilbanks GD, Fiorica J, Grendys Jr EC, LaPolla JP et al. (2004). Lysophospholipids are potential biomarkers of ovarian cancer. Cancer Epidemiol Biomarkers Prev 13: 1185–1191.

    CAS  PubMed  Google Scholar 

  • Waldeck-Weiermair M, Zoratti C, Osibow K, Balenga N, Goessnitzer E, Waldhoer M et al. (2008). Integrin clustering enables anandamide-induced Ca2+ signaling in endothelial cells via GPR55 by protection against CB1-receptor-triggered repression. J Cell Sci 121: 1704–1717.

    Article  CAS  PubMed  Google Scholar 

  • Whyte LS, Ryberg E, Sims NA, Ridge SA, Mackie K, Greasley PJ et al. (2009). The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo. Proc Natl Acad Sci USA 106: 16511–16516.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Xiao Y, Chen Y, Kennedy AW, Belinson J, Xu Y . (2000). Evaluation of plasma lysophospholipids for diagnostic significance using electrospray ionization mass spectrometry (ESI-MS) analyses. Ann N Y Acad Sci 905: 242–259.

    Article  CAS  PubMed  Google Scholar 

  • Xiao YJ, Schwartz B, Washington M, Kennedy A, Webster K, Belinson J et al. (2001). Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: comparison of the lysophospholipid contents in malignant vs nonmalignant ascitic fluids. Anal Biochem 290: 302–313.

    Article  CAS  PubMed  Google Scholar 

  • Yin H, Chu A, Li W, Wang B, Shelton F, Otero F et al. (2009). Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay. J Biol Chem 284: 12328–12338.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank Prof D Baker (Queen Mary University of London), Prof WH Moolenaar (The Netherlands Cancer Institute), Dr N Divecha (The Paterson Institute for Cancer Research, Manchester) and Dr R Sabatini (LPath Inc) for critical reading of the paper. We also thank the National Institute of Drug Abuse, Bethesda, MD, USA for providing SR141716A. RP was supported by the British Heart Foundation (grant PG/06/022/204348 to MF).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M Falasca.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Oncogene website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Piñeiro, R., Maffucci, T. & Falasca, M. The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation. Oncogene 30, 142–152 (2011). https://doi.org/10.1038/onc.2010.417

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2010.417

Keywords

This article is cited by

Search

Quick links